首页> 外国专利> ANTI-IGF-IR ANTIBODIES, THEIR PRODUCTION METHOD AND ITS USES, MURINO HIBRIDOMA, ISOLATED NUCLEIC ACID, VECTOR, COMPOSITION, KIT OR ASSEMBLY, AND IN VITRO DIAGNOSTIC METHOD OF DISEASES INDUCED BY AN EXPRESSION OF EXPRESSION OR REPRESSION

ANTI-IGF-IR ANTIBODIES, THEIR PRODUCTION METHOD AND ITS USES, MURINO HIBRIDOMA, ISOLATED NUCLEIC ACID, VECTOR, COMPOSITION, KIT OR ASSEMBLY, AND IN VITRO DIAGNOSTIC METHOD OF DISEASES INDUCED BY AN EXPRESSION OF EXPRESSION OR REPRESSION

机译:抗IGF-IR抗体,其生产方法及其用途,MURINO HIBRIDOMA,分离的核酸,矢量,成分,工具包或组件,以及通过表达或抑制表达诱发的疾病的体外诊断方法

摘要

"anti-igf-ir antibodies and their applications". the present invention relates to new antibodies capable of specifically binding to the human growth factor i receptor similar to the insulin igf-ir and / or capable of specifically inhibiting the tyrosine kinase activity of that igf-ir receptor, notably monocytes of murine origin , chimeric and humanized, as well as the amino acid and nucleic sequences encoding for these antibodies. the invention also encompasses the use of these antibodies as a medicine for the prophylactic and / or therapeutic treatment of cancers, as well as in processes or diagnostics necessary for diseases linked to the overexpression of the igf-ir receptor. the invention finally comprises products and / or compositions that comprise these antibodies in association with anti-egfr antibodies and / or compounds and / or anti-cancer agents or conjugated with toxins and their use for the prevention and / or treatment of certain cancers.
机译:“抗igf-ir抗体及其应用”。本发明涉及能够特异性结合类似于胰岛素igf-ir的人类生长因子i受体和/或能够特异性抑制该igf-ir受体的酪氨酸激酶活性的新抗体,特别是鼠源单核细胞,嵌合体和人源化,以及编码这些抗体的氨基酸和核酸序列。本发明还包括这些抗体作为药物用于预防和/或治疗癌症以及在与igf-ir受体过表达有关的疾病所必需的过程或诊断中的用途。本发明最终包括包含这些抗体与抗egfr抗体和/或化合物和/或抗癌剂或与毒素缀合的抗体的产品和/或组合物,以及它们在预防和/或治疗某些癌症中的用途。

著录项

  • 公开/公告号BRPI0306973B1

    专利类型

  • 公开/公告日2020-03-03

    原文格式PDF

  • 申请/专利权人 PIERRE FABRE MEDICAMENT;

    申请/专利号BR2003PI06973

  • 申请日2003-01-20

  • 分类号A01K67/027;A61K39/395;A61K31/4035;A61K31/415;A61K31/517;A61K31/519;A61K45;A61P17/06;A61P35;C07K16/28;C07K16/40;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N5/12;C12N9/99;C12N15;C12N15/09;C12N15/20;C12P21/08;G01N33/53;G01N33/68;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:14

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号